BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21843977)

  • 1. DNA damage response, genetic instability and cancer: from mechanistic insights to personalized treatment.
    Bartek J
    Mol Oncol; 2011 Aug; 5(4):303-7. PubMed ID: 21843977
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting DNA Repair.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():161-180. PubMed ID: 30341723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microsatellite instability and cancer: from genomic instability to personalized medicine].
    Collura A; Lefevre JH; Svrcek M; Tougeron D; Zaanan A; Duval A
    Med Sci (Paris); 2019; 35(6-7):535-543. PubMed ID: 31274083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin and genomic instability in cancer.
    Weyemi U; Galluzzi L
    Int Rev Cell Mol Biol; 2021; 364():ix-xvii. PubMed ID: 34507786
    [No Abstract]   [Full Text] [Related]  

  • 5. Endogenous DNA Damage as a Source of Genomic Instability in Cancer.
    Tubbs A; Nussenzweig A
    Cell; 2017 Feb; 168(4):644-656. PubMed ID: 28187286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair defects and implications for immunotherapy.
    Bever KM; Le DT
    J Clin Invest; 2018 Oct; 128(10):4236-4242. PubMed ID: 30272580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting DNA repair defects for novel cancer therapies.
    van Gent DC; Kanaar R
    Mol Biol Cell; 2016 Jul; 27(14):2145-8. PubMed ID: 27418635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy.
    Huang R; Zhou PK
    Signal Transduct Target Ther; 2021 Jul; 6(1):254. PubMed ID: 34238917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA replication and cancer: From dysfunctional replication origin activities to therapeutic opportunities.
    Boyer AS; Walter D; Sørensen CS
    Semin Cancer Biol; 2016 Jun; 37-38():16-25. PubMed ID: 26805514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis.
    Bindra RS; Glazer PM
    Mutat Res; 2005 Jan; 569(1-2):75-85. PubMed ID: 15603753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between the DNA Damage Response and Immunotherapy Response in Cancer.
    Lee ECY; Kok JST; Teh BT; Lim KS
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
    Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
    Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic instability: on the birth and death of cancer.
    Murga M; Fernández-Capetillo O
    Clin Transl Oncol; 2007 Apr; 9(4):216-20. PubMed ID: 17462973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic instability and cancer.
    Charames GS; Bapat B
    Curr Mol Med; 2003 Nov; 3(7):589-96. PubMed ID: 14601634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide Excision Repair: From Neurodegeneration to Cancer.
    Liakos A; Lavigne MD; Fousteri M
    Adv Exp Med Biol; 2017; 1007():17-39. PubMed ID: 28840550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in mutagenesis, genomic instability, and DNA repair.
    Landau DA; Slack FJ
    Semin Oncol; 2011 Dec; 38(6):743-51. PubMed ID: 22082760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage: from causes to cures.
    Bowater RP; Borts RH; White MF
    Biochem Soc Trans; 2009 Jun; 37(Pt 3):479-81. PubMed ID: 19442241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic instability as a driver for oncogenesis].
    Cazaux C
    Bull Cancer; 2010 Nov; 97(11):1241-51. PubMed ID: 21084240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diseases of repair].
    Girard PM
    Bull Cancer; 2021 Mar; 108(3):235-238. PubMed ID: 33423783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.